(Q79790306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

The accelerated biased coin up-and-down design in phase I trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

main subject

phase I clinical trial

1 reference

Mario Stylianou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Dean A Follmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biopharmaceutical Statistics

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

249-260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

Sequential designs for phase I clinical trials with late-onset toxicities

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

A random walk rule for phase I clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Some practical improvements in the continual reassessment method for phase I studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

A comparison of two phase I trial designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Isotonic designs for phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Continual reassessment method: a likelihood approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Dose finding using the biased coin up-and-down design and isotonic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Estimating the probability of toxicity at the target dose following an up-and-down design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

Accrual strategies for phase I trials with delayed patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FBIP-120028518

21 January 2018

Identifiers

DOI

10.1081/BIP-120028518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15027512%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference